These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14279888)

  • 1. ON THE SUBSTRATE CHARACTERISTICS OF 5-HYDROXYTRYPTAMINE-CERULOPLASMIN TREATED HUMAN FIBRIN EXPOSED TO FIBRINOLYTIC AGENTS.
    AUERSWALD W; BERNHEIMER H; DOLESCHEL W
    Med Pharmacol Exp Int J Exp Med; 1965; 12():81-91. PubMed ID: 14279888
    [No Abstract]   [Full Text] [Related]  

  • 2. ON THE PLASMINOGEN ACTIVATOR FORMING CAPACITY OF HUMAN PLASMA GLOBULINS REACTING WITH STREPTOKINASE.
    AUERSWALD W; DOLESCHEL W
    Med Exp Int J Exp Med; 1964; 10():179-84. PubMed ID: 14129855
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE SOLUBILITY OF FIBRIN DEPOSITS].
    HEY D; BENEKE G
    Verh Dtsch Ges Pathol; 1963; 47():232-4. PubMed ID: 14168358
    [No Abstract]   [Full Text] [Related]  

  • 4. FIBRINOLYTIC AND ESTEROLYTIC ACTIVITY OF HUMAN PLASMA.
    ADAMIS DM; MANIATIS GM
    Thromb Diath Haemorrh; 1965 Jun; 13():484-91. PubMed ID: 14347870
    [No Abstract]   [Full Text] [Related]  

  • 5. THE FIBRINOLYTIC SYSTEM DURING THE MENSTRUAL CYCLE.
    BELLER FK; GOEBELSMANN U; DOUGLAS GW; JOHNSON A
    Obstet Gynecol; 1964 Jan; 23():12-6. PubMed ID: 14110046
    [No Abstract]   [Full Text] [Related]  

  • 6. INCREASE IN FIBRINOLYTIC ACTIVITY BY VENOUS OCCLUSION.
    HOLEMANS R
    J Appl Physiol; 1963 Nov; 18():1123-9. PubMed ID: 14080731
    [No Abstract]   [Full Text] [Related]  

  • 7. FIBRINOGEN BREAKDOWN PRODUCTS.
    LEWIS JH; WILSON JH
    Am J Physiol; 1964 Nov; 207():1053-7. PubMed ID: 14237449
    [No Abstract]   [Full Text] [Related]  

  • 8. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON INTRAVASCULAR CLOT LYSIS.
    LEWIS JH; KERBER CW; WILSON JH
    Am J Physiol; 1964 Nov; 207():1044-8. PubMed ID: 14237447
    [No Abstract]   [Full Text] [Related]  

  • 9. FIBRINOLYSIS.
    ADAMIS D
    Conn Med; 1964 Sep; 28():662-7. PubMed ID: 14201318
    [No Abstract]   [Full Text] [Related]  

  • 10. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS.
    TYLER HM; LACK CH
    Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258
    [No Abstract]   [Full Text] [Related]  

  • 11. RADIOACTIVE (I-125) HUMAN PLASMA CLOTS FOR ASSAY OF THROMBOLYTIC ACTIVITY.
    HUME M
    J Lab Clin Med; 1964 Apr; 63():699-702. PubMed ID: 14155458
    [No Abstract]   [Full Text] [Related]  

  • 12. [THE PROACTIVATOR OF THE FIBRINOLYTIC SYSTEM IN VENOUS BLOOD OF THE UMBILICAL CORD AND OF OLDER INFANTS].
    KUENZER W; MARKEL A
    Ann Paediatr; 1964; 202():278-84. PubMed ID: 14135039
    [No Abstract]   [Full Text] [Related]  

  • 13. FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE).
    JAMES DC; BROWSE NL
    Br J Clin Pract; 1964 Jun; 18():343-56. PubMed ID: 14169065
    [No Abstract]   [Full Text] [Related]  

  • 14. SOME CONSIDERATIONS IN THE SYSTEMIC USE OF FIBRINOLYTIC AGENT.
    COON WW
    Mich Med; 1964 Jul; 63():488-90. PubMed ID: 14182774
    [No Abstract]   [Full Text] [Related]  

  • 15. EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD.
    BRAKMAN P; ASTRUP T
    Lancet; 1964 Jul; 2(7349):10-2. PubMed ID: 14149193
    [No Abstract]   [Full Text] [Related]  

  • 16. [Research on the antifibrinolytic effect of 6-aminocaproic acid. III. Effect of 6-aminocaproic acid as an antidote to thrombolytic agents (plasmin, streptokinase)].
    GIBELLI A
    Gazz Int Med Chir; 1962 Nov; 66():2444-50. PubMed ID: 13947688
    [No Abstract]   [Full Text] [Related]  

  • 17. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS.
    BACK N; HIRAMOTO R; AMBRUS JL
    Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of trypsin on the fibrinolytic system of normal serum treated with plasmin or streptokinase].
    GIACOMAZZI G
    Haematologica; 1962; 47():875-906. PubMed ID: 13947574
    [No Abstract]   [Full Text] [Related]  

  • 19. [FIBRINOLYSIS INHIBITORS AND DETERMINATION OF PHYSIOLOGICAL AND PATHOLOGICAL ANTIPLASMIN ACTIVITY].
    MORIAU M; DE VRIES SI; DIK HJ
    Thromb Diath Haemorrh; 1964 Jan; 10():355-78. PubMed ID: 14113376
    [No Abstract]   [Full Text] [Related]  

  • 20. Assay of thrombolytic ('fibrinolytic') mixtures intended for therapeutic use.
    FLETCHER AP; ALKJAERSIG N; SHERRY S
    J Lab Clin Med; 1961 Apr; 57():620-9. PubMed ID: 13700257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.